Evidence map›Paper›PMID 34241641›Full record

ArticleDer Urologe. Ausg. A2021

[Occupational cancers in urology].

Klaus Golka, Ralf Böthig, Olaf Jungmann, Martin Forchert, Micha El Zellner, Wolfgang Schöps

Abstract read
PubMed Publisher
In one paragraph

Article in Der Urologe. Ausg. A, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Klaus GolkaLeibniz-Institut für Arbeitsforschung an der TU Dortmund (IfADo), Ardeystr. 67, 44139, Dortmund, Deutschland. golka@ifado.de.
Ralf BöthigAbteilung Neuro-Urologie, BG Klinikum Hamburg, Hamburg, Deutschland.
Olaf JungmannUrologische Klinik Lindenthal, Malteser Krankenhaus St. Hildegardis, Köln, Deutschland.
Martin ForchertStabsstelle UV-Recht, Berufsgenossenschaft Holz und Metall, Bielefeld, Deutschland.
Micha El ZellnerAbteilung Urologie und Neurourologie, Johannesbad Fachklinik, Bad Füssing, Deutschland.
Wolfgang Schöps, Sankt Augustin, Deutschland.
Asklepios Klinik Sankt Augustin · DEBG Klinikum Hamburg · DELeibniz Research Centre for Working Environment and Human Factors · DEMalteser-Krankenhaus · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancers can be triggered by occupational causes. In the field of urology, bladder cancer is by far the most frequent occupationally induced tumor disease. Causes are particularly carcinogenic aromatic amines and carcinogenic polycyclic aromatic hydrocarbons. The frequency of this disease has shifted over the last decades from the classical hazard in the chemical industry to the users. Among a variety of hazardous occupations, hairdressers and painters are the best known. Rarely, renal cell carcinoma can be triggered by high trichloroethylene exposure and mesothelioma of the tunica vaginalis testis by asbestos. If a disease that can be caused by occupational activities has been confirmed (e.g. urinary bladder cancer), the risk factors must be recorded by a complete occupational history from the first employment on in order to be able to report a suspected occupational disease. In addition, spinal cord injury due to occupational and commuting accidents can lead to urinary bladder cancer over the long term.

Indexed as

Kidney NeoplasmsOccupational DiseasesOccupational ExposureUrinary Bladder NeoplasmsUrologyHumansMaleAromatic aminesCarcinogensOccupational diseasesRenal cell carcinomaUrinary bladder neoplasms

Identifiers

PMID34241641
OpenAlexW3178064461

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.